Anti-inflammatory agents developed by UBC microbiologist Robert Hancock, used in combination with anti-malarial drugs, have been shown to boost survival rates of severe malaria by as much as 50 per cent.
Anti-inflammatory agents developed by UBC microbiologist Robert Hancock, used in combination with anti-malarial drugs, have been shown to boost survival rates of severe malaria by as much as 50 per cent.
University of British Columbia researcher Hongshen Ma has developed a simple and accurate device to study malaria, a disease that currently affects 500 million people per year worldwide and claims a million lives.